The city's pharmaceutical and healthcare industry chamber's key enterprise event, "Sci-Tech Innovation Salon: Connecting Hearts, Warmly Supporting Businesses," was held at the company.

To further understand the technological innovation needs of pharmaceutical and healthcare enterprises, better serve these companies with innovation-related services, continuously enhance their innovative capabilities, and promote the high-quality development of our city's pharmaceutical and healthcare industry, the Municipal Science and Technology Bureau and the Municipal Federation of Industry and Commerce jointly held the "Sci-Tech Innovation Salon: Connecting Hearts, Warmly Supporting Enterprises" event for key enterprises of the Pharmaceutical Chamber on October 26.

Leaders attending the meeting included Li Xiuwu, Director of the Municipal Science and Technology Bureau, and Li Yanfu, Deputy Director; Xue Jun, Vice Chairman of the Municipal Federation of Industry and Commerce. Participating companies were represented by executives from Boda Weiye, Boda Pharmaceutical, Yin Ying Pharmaceutical, Baikang Pharmaceutical, Forte Pharma, Yadong Pharmaceutical, Hongyuan Pharmaceutical, Zhenyu Pharmaceutical, Xinhui Pharmaceutical, Dikang Pharmaceutical, and Meiluo Pharmaceutical, among others.

This conference is divided into three parts: The first part features the promotion of motor energy-saving project achievements from Zhejiang Tsinghua Yangtze River Delta Research Institute, themed "Energy Conservation and Transformation Drive Development; Green, Low-Carbon Practices Secure the Future." The second part involves Jilin Province Bodaweiyi Pharmaceutical Co., Ltd. presenting the results of their enterprise verification process for the motor energy-saving project. The third part consists of a roundtable discussion among representatives from the Municipal Science and Technology Bureau, the Municipal Federation of Industry and Commerce, and participating companies, focusing on addressing key challenges related to the current business operations and growth of leading enterprises in the pharmaceutical and healthcare industry, including new product development, platform construction, industry-academia-research collaboration, and access to financing services.